Literature DB >> 19097943

Profile of adults with congenital heart disease having a good, moderate, or poor quality of life: a cluster analytic study.

Philip Moons1, Kristien Van Deyk, Kristel Marquet, Leentje De Bleser, Sabina De Geest, Werner Budts.   

Abstract

AIMS: The purpose of the study was to assess the profile of adult patients with congenital heart disease who reported a good, moderate, or poor quality of life.
METHODS: We conducted a secondary analysis of data from a large-scale quality-of-life study that included 627 patients. Demographic and clinical variables were retrieved from the medical records and functional status from patient interviews. Overall quality of life was measured using a Linear Analogue Scale. Using K-means cluster analysis, we categorized subjects into a 3-cluster solution: good, moderate, or poor quality of life.
RESULTS: Four hundred ninety patients (78.1%) clustered into the good quality-of-life category; 126 patients (20.1%) clustered into the moderate quality-of-life category; and 11 patients (1.8%) clustered into the poor quality-of-life category. Poorer quality of life was associated with lower educational level, unemployment or disability, associated syndromes, instability of the heart disease, and a poorer functional status.
CONCLUSION: Over three-quarters of the patients had a good quality of life, whereas only a small proportion had a poor quality of life. Specific demographic and clinical characteristics associated with a poor quality of life could assists in identifying patients at risk for developing a poor quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 19097943     DOI: 10.1016/j.ejcnurse.2008.11.001

Source DB:  PubMed          Journal:  Eur J Cardiovasc Nurs        ISSN: 1474-5151            Impact factor:   3.908


  6 in total

1.  The importance of socio-demographic factors for the quality of life of adults with congenital heart disease.

Authors:  Matthäus Vigl; Eva Niggemeyer; Alfred Hager; Gerda Schwedler; Siegfried Kropf; Ulrike Bauer
Journal:  Qual Life Res       Date:  2010-11-02       Impact factor: 4.147

Review 2.  Health-related quality of life in adults with tetralogy of Fallot repair: a systematic review and meta-analysis.

Authors:  Mahim Malik; Zaiba Shafik Dawood; Mahin Janjua; Sardar Shahmir Babar Chauhan; Laila Akbar Ladak
Journal:  Qual Life Res       Date:  2021-05-22       Impact factor: 4.147

3.  Quality of life experienced by adolescents and young adults with congenital heart disease.

Authors:  Flávio Miguel Teixeira; Rosália Maria Coelho; Cidália Proença; Ana Margarida Silva; Daniela Vieira; Cláudia Vaz; Cláudia Moura; Victor Viana; José Carlos Areias; Maria Emília Guimarães Areias
Journal:  Pediatr Cardiol       Date:  2011-06-28       Impact factor: 1.655

4.  Long term psychosocial outcomes of congenital heart disease (CHD) in adolescents and young adults.

Authors:  Maria Emília Guimarães Areias; Catarina I Pinto; Patrícia F Vieira; Flávio Teixeira; Rosália Coelho; Isabela Freitas; Samantha Matos; Marta Castro; Sofia Sarmento; Victor Viana; Jorge Quintas; José C Areias
Journal:  Transl Pediatr       Date:  2013-07

5.  Phenotypes of adults with congenital heart disease around the globe: a cluster analysis.

Authors:  Edward Callus; Silvana Pagliuca; Sara Boveri; Federico Ambrogi; Koen Luyckx; Adrienne H Kovacs; Silke Apers; Werner Budts; Junko Enomoto; Maayke A Sluman; Jou-Kou Wang; Jamie L Jackson; Paul Khairy; Stephen C Cook; Shanthi Chidambarathanu; Luis Alday; Katrine Eriksen; Mikael Dellborg; Malin Berghammer; Bengt Johansson; Andrew S Mackie; Samuel Menahem; Maryanne Caruana; Gruschen Veldtman; Alexandra Soufi; Susan M Fernandes; Kamila White; Shelby Kutty; Philip Moons
Journal:  Health Qual Life Outcomes       Date:  2021-02-10       Impact factor: 3.186

6.  Educational attainment in patients with congenital heart disease: a comprehensive systematic review and meta-analysis.

Authors:  Lucia Cocomello; Arnaldo Dimagli; Giovanni Biglino; Rosie Cornish; Massimo Caputo; Deborah A Lawlor
Journal:  BMC Cardiovasc Disord       Date:  2021-11-19       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.